| 
Results for amgen. Search took 0.35 seconds.
Tag der Organspende - beispielhaft: Aktion in Hannover
in Das Gesundheits-Weblog, on 05.06.08
...sche Nephrologie und der Deutschen Nierenstiftung. Unterstützt wird die Aktion von den Firmen Amgen, Fresenius, Servier und der Techniker Krankenkasse.
Ziel der Aktion ist es, am Tag der Organspende ...
Carl Icahn 将正式卷起新 Yahoo 收购风波
in Wangtam, on 2008-05-17
刚刚已经提及， 亿万富翁 Carl Icahn 上周谋得 Yahoo 董事席位，意欲发动代理权争夺战 。然后 Carl Icahn 在随后发给 Yahoo 的信中确认，他已经发动了旨在促成微软收购 Yahoo 的代理权争夺战。 Carl Icahn 已经提名了十位 Yahoo 董事候选人，希望用他们取代现有 Yahoo 董事会，以推动 Yahoo 接受微软每股 33 美元、总价值 475 亿美元的收购报价。 Carl Icahn 还在写给 Yahoo 董事会主席 Roy Bostock 的信中披露，他已经收购了 5900 万股 Yahoo 股票，并在寻求清除来自国美国联邦贸易委员会的反垄...
Amgen Buys Ilypsa for $420 Million
in The Biotech Weblog, on June 6, 2007
...
Biotech giant Amgen, Inc has agreed to buy Ilypsa , a privately-held, Sand Francisco based firm focusing on the development of drugs against kidney disease, for $420 million. Ilypsa's lead ...
IBF Holds its 7th Annual Supply Chain Planning and Forecasting Conference
in Supplychainer, on February 5, 2007
...chain practices, including those that have succeeded at Hewlett-Packard, Intel, Ebay, kraft , Amgen, Gerber, and more. The IBF's Sales and Operations Planning (S&OP) workshop will examin...
Big Biotech Stocks To Perform Better in 2007
in The Biotech Weblog, on January 12, 2007
... 2006 hasn't been a good year for biotech firms, but analysts say big biotech companies like Amgen , Genentech , Celgene and Gilead Sciences would perform better in 2007.
"We're ...
Top 20 Employers in the Biotech and Pharmaceutical Industries
in The Biotech Weblog, on October 23, 2006
... a ranking of 90 to 100. The second tier, with scores between 80 and 89, includes, in order, Roche, Amgen, AstraZeneca , and Genzyme. And completing the top 10 in a third tier, with scores of 70...
Amgen Seeks Banning of Roche's Anemia Drug, Cera
in The Biotech Weblog, on April 12, 2006
... Biopharmaceutical giant Amgen has filed a claim with the US International Trade Commission requesting for a ban on imports of an experimental anemia drug called Cera , manufactured by Roc...
Amgen's Denosumab Increases Bone Mineral Density in Phase 2 Clinical Trials
in The Biotech Weblog, on February 27, 2006
...
Amgen released the results of Phase 2 clinical trials for Denosumab (previously referred to as AMG 162), showing that the RANK Ligand inhibitor significantly increased bone mineral densi...
Amgen Gains Worldwide Rights to Biovitrum's Lead Candidate For Type 2 Diabetes
in The Biotech Weblog, on February 14, 2006
...
In a revised, expanded agreement , Amgen receives exclusive worldwide rights to develop and commercialize Biovitrum 's drug candidate for Type 2 diabetes and related metabolic Disease...
Top Five Regions For Biotech Companies
in The Biotech Weblog, on January 26, 2006
...
California
California is building on one of the biggest life sciences bases in the world. Amgen and Genentech are just two of the biotech stars based in the state, and Stanford recent...
Will Biotech Be Good Bets in 2006?
in The Biotech Weblog, on January 6, 2006
...N Money , biotech will remain to be good bets, if the successes and potentials of companies such as Amgen and Genentech were to be based upon.
"These companies are Flush with new products...
Amgen Acquires Abgenix for $2.2 B
in The Biotech Weblog, on December 15, 2005
...
Amgen and Abgenix have been collaborating on developing two major cancer drug candidates, one of which, panitumumab , has been shown effective against colorectal cancer therapy in its Phase 3 cl...
Bio-Partnering on the Horizon in China
in China Venture News, on December 13, 2005
...king for in Western partners? Top executives from IBM Healthcare and Life Sciences Group, Deloitte, Amgen, Roche, Eli Lilly, GSK, Pfizer, Perkins Coie, Heller Ehrman, Epitomics, BioMarker, excel ...
Amgen Sues Roche Over Anemia Drug
in The Biotech Weblog, on November 10, 2005
...
Amgen Inc. is suing Swiss pharma Roche Holding AG for allegedly infringing patents behind Amgen's anemia drug, Epogen . The bone of contention is that Roche's version of the anem...
Serono Hold Talks With Biopharmaceutical Giants For Potential Take-over
in The Biotech Weblog, on November 9, 2005
...ion takeover. Interested parties were: Novartis, GlaxoSmithKline, Sanofi- Aventis and Pfizer. Amgen bows out, Roger Perlmutter, vice-president of research and development saying
"I don&...
Seven Technologies That Change Everything
in Wangtam, on 2005-10-10
...ic forms of the patented drug proteins sold by big biotech firms. WHY IT'S HOT: Companies like Amgen (AMGN) and Genentech (DNA) rely heavily on expensive but effective protein-based therapies for...
Top 100 Biotechnology Companies 2004
in The Biotech Weblog, on July 14, 2005
...
MedAd News releases a list of top 100 biotechnology companies based on revenues. Amgen and Genetech top the list, with Amgen recording a total revenue of $10.55 billion in 2004 that tr...